← All trials
NCT06161025
Phase 2/Phase 3Interventional
Trials that are a combination of phases 2 and 3.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Feb 29, 2024
- Primary completion
- Dec 31, 2027
- Completion date
- Dec 31, 2029
- First posted
- Dec 7, 2023
- Last posted
- Dec 14, 2023
- Enrollment
- 650
- Arms / groups
- 5 / —
- Source
- AACT · ctgov ingestion
Sponsors
- Daiichi SankyoLead sponsor
- Daiichi SankyoStudy director
- MerckCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.